Sale

Coastal Capital Acquisition Corporation Reverse Stock Split

Retrieved on: 
Saturday, December 3, 2022
Transfer, FINRA, Reverse stock split, OTC Markets Group, Strategic partnership, Sale, SIC, News, Growth, Acquisition, Security (finance)

No fractional shares will be issued in connection with the reverse stock split and the par value remains unchanged.

Key Points: 
  • No fractional shares will be issued in connection with the reverse stock split and the par value remains unchanged.
  • Shareholders holding stock certificates may contact the Companys transfer agent, Pacific Stock Transfer Company for details on how to exchange for new stock certificates.
  • Coastal Capital Acquisition Corporation believes it is placed precisely, in terms of long-term growth and stability, and looks toward the future endeavors of the company.
  • As a result of the reverse stock split, every 10 shares of outstanding common stock will be exchanged for 1 share of common stock, with any fractional shares being rounded up to the next higher whole share.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vintage Wine, SolarEdge, Unisys, and Rent the Runway and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, December 3, 2022
United States District Court for the Eastern District of Texas, RTR, IPO, District court, Registration statement, SolarEdge, Defendant, Rent the Runway, UIS, Communication, United States International Trade Commission, Sale, Jewellery, NYSE, Unisys, PV, Form, VWE, Vintage Wine, EBITDA, Lilliput Kidswear, COVID-19, News, Growth, Prospectus, DC, Wine, Marketing, Register, Patent, Holding company, Renewable energy, Risk management, Audit, Pharmaceutical industry, Property management, AMPT, P.C

On September 13, 2022, Vintage Wine announced its financial results for fiscal year 2022.

Key Points: 
  • On September 13, 2022, Vintage Wine announced its financial results for fiscal year 2022.
  • Throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects.
  • For more information on the Rent the Runway class action go to: https://bespc.com/cases/RENT
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at November 30, 2022

Retrieved on: 
Saturday, December 3, 2022
Annual report, NYSE, Investment Company Act of 1940, Sale, Communication, Policy, Security (finance), Financial adviser

The mention of specific securities is not a recommendation or solicitation for any person to buy, sell or hold any particular security.

Key Points: 
  • The mention of specific securities is not a recommendation or solicitation for any person to buy, sell or hold any particular security.
  • You can obtain a complete listing of holdings by viewing the Companys most recent quarterly or annual report.
  • The company's investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to stockholders.
  • KYN intends to achieve this objective by investing at least 80% of its total assets in securities of Energy Infrastructure Companies.

Kayne Anderson NextGen Energy & Infrastructure Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at November 30, 2022

Retrieved on: 
Saturday, December 3, 2022
Fund, KMF, Investment Company Act of 1940, Plains All American Pipeline, Energy, Energy transition, Sale, Communication, NYSE, Investment, Policy, Annual report, Renewable energy transition, Security (finance), Financial adviser

The mention of specific securities is not a recommendation or solicitation for any person to buy, sell or hold any particular security.

Key Points: 
  • The mention of specific securities is not a recommendation or solicitation for any person to buy, sell or hold any particular security.
  • You can obtain a complete listing of holdings by viewing the Funds most recent quarterly or annual report.
  • Kayne Anderson NextGen Energy & Infrastructure, Inc. (NYSE: KMF) is a non-diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended, whose common stock is traded on the NYSE.
  • Kayne Anderson undertakes no obligation to publicly update or revise any forward-looking statements made herein.

Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement

Retrieved on: 
Saturday, December 3, 2022
RSU, Disorder, Psilocybin, Person, Exercise, Bright Minds In Action Learning Village, National instrument, Option, CSE, Sale, NEWS, Epilepsy, PTSD, King Salmon, Alaska, Pain, Drug development, Part, News, PFW, Depression, Security (finance), Pharmaceutical industry, Unit

VANCOUVER, British Columbia, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) (“Bright Minds” or the “Company”) is pleased to announce that, further to its news release on November 28, 2022, it has closed a non-brokered private placement of (i) 666,000 pre-funded warrants of the Company (“PFWs”) at a price of $1.249 per PFW (the “PFW Offering”), and (ii) 974,000 units of the Company (“Units”) at a price of $1.25 per Unit (the “Unit Offering”), for aggregate gross proceeds of $2,049,334.

Key Points: 
  • Each Unit is comprised of one common share in the capital of the Company (a Share) and one common share purchase warrant (a Warrant).
  • Bright Minds is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
  • Bright Minds has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain.
  • Bright Minds drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Palladium One Announces Increase in Brokered Private Placement Financing from C$3 million to C$4.2 million

Retrieved on: 
Friday, December 2, 2022
Income Tax Act, Canada Revenue Agency, Section 50C of the Isle of Man Income Tax Act 1970, Rail transport by country, TSX Venture Exchange, Oil Taxation Act 1975, Person, Corporation, LK, Indian stock exchange, National instrument, PGE, Sale, Palladium, Lead, Agent, Metal, Charity, FSE, Offering, News, Failure, PDM, Tax, Prospectus, Resource management, Security (finance), Tyko

TORONTO, ON, Dec 3, 2022 - (ACN Newswire) - Palladium One Mining Inc. (TSXV: PDM) (OTCQB: NKORF) (FSE: 7N11) (the "Company" or "Palladium One") is pleased to announce that it has increased the previously announced brokered private placement from $3 million to $4.2 million.

Key Points: 
  • TORONTO, ON, Dec 3, 2022 - (ACN Newswire) - Palladium One Mining Inc. (TSXV: PDM) (OTCQB: NKORF) (FSE: 7N11) (the "Company" or "Palladium One") is pleased to announce that it has increased the previously announced brokered private placement from $3 million to $4.2 million.
  • In addition, the Company's non-brokered flow-through unit financing ("FT Units") to be issued at unit price ("FT Unit Price") remains unchanged.
  • Palladium One Mining Inc. (TSXV: PDM) is focused on discovering environmentally and socially conscious Metals for Green Transportation.
  • A Canadian mineral exploration and development company, Palladium One is targeting district scale, platinum-group-element (PGE)-copper-nickel deposits in Canada and Finland.

Poet Technologies Announces Closing of C$4.4 Million Private Placement of Units

Retrieved on: 
Friday, December 2, 2022
Programmable interrupt controller, PTK, TSX Venture Exchange, Person, Warrant, Related party transaction, Multilateral, Sale, FOR, US, POET, IOT, IBK, Die (integrated circuit), Offering, News, Artificial intelligence, Internet of things, Minority, MI, Electronics, NOT, Legislation, Indian stock exchange, Security (finance), Bank, Corporation, Unit

TORONTO, Dec. 02, 2022 (GLOBE NEWSWIRE) -- POET Technologies Inc. ("POET" or the "Corporation") (TSXV: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, announces that it has completed its previously announced non-brokered private placement (the "Offering") of an aggregate 1,126,635 units of the Corporation (the "Units") at a price of C$3.81 (US$2.78) per Unit for aggregate gross proceeds of C$4,292,479.35 (US$3,132,045.30).

Key Points: 
  • Each Warrant entitles the holder thereof to purchase one Common Share at an exercise price of C$4.95 (US$3.61) per Common Share for a period of three years following the closing date of the Offering.
  • Glen Riley, a director of the Corporation, subscribed for 10,000 Units under the Offering for gross proceeds of C$38,100 (US$27,800).
  • POETs Optical Interposer eliminates costly components and laborintensive assembly, alignment, burnin and testing methods employed in conventional photonics.
  • POET is headquartered in Toronto, with operations in Allentown, PA, Shenzhen, China and Singapore.

Guggenheim Energy & Income Fund Announces Tender Offer

Retrieved on: 
Friday, December 2, 2022
Fund, Investment Company Act of 1940, Tender offer, Letter, Investment, GS, Securities Investor Protection Corporation, Sale, Guggenheim Partners, Liquidity, Financial adviser, Consultant, NAV, Eastern Time Zone, FUND, Insurance, Risk, Security (finance), Money transmitter

NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Guggenheim Energy & Income Fund (the “Fund”) (XGEIX) announced today a tender offer to purchase for cash up to 2.5% of the Fund’s issued and outstanding common shares of beneficial interest (“common shares”). The tender offer will be conducted at a price equal to the Fund’s net asset value per common share on the date on which the tender offer expires. The Fund intends to commence the tender offer on or about Friday, December 2, 2022, with the expiration of the tender offer currently expected to take place on Tuesday, January 3, 2023 at 5:00 p.m., Eastern Time, unless otherwise extended.

Key Points: 
  • NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Guggenheim Energy & Income Fund (the Fund) (XGEIX) announced today a tender offer to purchase for cash up to 2.5% of the Funds issued and outstanding common shares of beneficial interest (common shares).
  • As soon as the tender offer commences, the Fund will file a tender offer statement on Schedule TO with the SEC, which will include an Offer to Purchase and related Letter of Transmittal.
  • Questions regarding the Tender Offer may be directed to Georgeson LLC, the information agent for the tender offer, at (888) 565-5190.
  • Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Partners Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management.

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Friday, December 2, 2022
CDK, Fast track (FDA), Financial compensation, Patient, Sale, Employment, SERD, Ribociclib, SAN, Pharmaceutical industry

These awards were approved by the Compensation Committee of Olemas Board of Directors and granted under the Company's 2022 Inducement Plan, with a grant date of December 1, 2022, as an inducement material to the new employee entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • These awards were approved by the Compensation Committee of Olemas Board of Directors and granted under the Company's 2022 Inducement Plan, with a grant date of December 1, 2022, as an inducement material to the new employee entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The stock options are subject to the terms of the Olema Pharmaceuticals, Inc., 2022 Inducement Plan.
  • Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for womens cancers.
  • Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts.

Mercurity Fintech Holding Inc. Announced Closing of $5 Million Private Investment in Public Equity (PIPE) Financing

Retrieved on: 
Friday, December 2, 2022
Bitcoin, Security (finance), MFH, Sale, New York State Department of Financial Services, SPA, Financial services, PIPE, Revenue, Cryptocurrency

Net proceeds from the PIPE financing are expected to be used to advance the Companys business development activities for working capital and other general corporate purposes.

Key Points: 
  • Net proceeds from the PIPE financing are expected to be used to advance the Companys business development activities for working capital and other general corporate purposes.
  • About Mercurity Fintech Holding Inc.
    Mercurity Fintech Holding Inc. is a digital fintech group powered by blockchain technology.
  • The Company recently began to narrow in on Bitcoin mining, digital currency investment and trading, and other related fields.
  • This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.